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genital ulcer disease (GUD). The second questionnaire targeted
pharmacists working in both public and private health care facili-
ties to elicit information on prescribing and dispensing practices.
RESULTS: The availability of acyclovir in the public sector was
a function of funding and prioritisation by policy makers. In
Zimbabwe and Zambia for example, acyclovir was unavailable
in the public sector because of a paucity of funds, while in Kenya,
Tanzania and South Africa, accessibility to acyclovir in the public
sector was poor because of low prioritisation by policy makers.
Acyclovir was available in the private sector, albeit at higher
prices than the private sector. Despite the availability of generic
formulations and the presence of competitive markets, acyclovir
was described as “poorly affordable” in the private sectors of all
countries except Botswana, South Africa and Zambia. Moreover,
private sector pharmacies used information asymmetry to inﬂate
the price of acyclovir generics from European countries as a
signal of quality. CONCLUSION: On-going clinical trials may
determine acyclovir to be effective in preventing the transmission
of human immunodeﬁciency virus (HIV) to susceptible patients.
However, for this research to transition into policy, certain fun-
damental issues will need to be addressed. These include: infor-
mation dissemination on the importance of acyclovir in GUD
and HIV to policy makers and the general public; and the need
for government intervention into competitive markets because of
inequalities to access and information asymmetry.
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OBJECTIVE: Hepatitis C virus (HCV) is a common blood-borne
infection in the US. Over time, patients with chronic HCV can
encounter serious complications that impose a signiﬁcant cost
burden to third party payers. In this study, we generated national
estimates of inpatient costs, length of stay (LOS), and probability
of death associated with four major chronic HCV-related com-
plications. METHODS: Discharge data for patients with chronic
HCV (ICD-9 070.44, 070.54, 070.70, or 070.71) were analyzed
using the 2005 HCUP Nationwide Inpatient Sample. Discharges
related to ascites, variceal bleeding, hepatic encephalopathy, and
hepatocellular carcinoma (hepatoma) were identiﬁed using rel-
evant ICD-9 diagnosis codes. Weighted estimates of costs, LOS,
and probability of death were calculated for stays related to these
complications. RESULTS: We identiﬁed a weighted total of
275,737 chronic HCV-related discharges. Approximately 11.5%
of these discharges were for ascites and 5.6% were for hepatic
encephalopathy. Admissions for variceal bleeding and hepatoma
were less common at 0.3% and 2.8%, respectively. Hepatoma,
however, was associated with the highest total inpatient costs
($17,609) and LOS (6.3 days). The probability of death from
hepatoma was 11%. Patients had 7.3 inpatient days on average
for ascites with a cost per day of $2125 and total inpatient cost
of $14,858. The probability of death from ascites was 9%. The
average number of inpatient days for hepatic encephalopathy
was 7 days with a cost per day of $1936, total inpatient cost of
$13,380, and probability of death of 11%. Patients with variceal
bleeding had the lowest inpatient costs ($12,128) and LOS (5.4
days). The probability of death from variceal bleeding (8%) was
lower compared to the other complications. CONCLUSION:
Advanced chronic HCV can lead to serious and costly com-
plications. Efforts to improve HCV treatment may help slow
disease progression and thus result in cost savings from avoided
complications.
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OBJECTIVE: Nosocomial infections are increasing. This study
focuses on soft tissue infections, S aureus infections and MRSA
nosocomial infections. Trends are quantiﬁed and analyzed for
hospital and patient characteristics. METHODS: Data from the
HCUP National Inpatient Sample (NIS) of US hospital discharges
for 1998 through 2004 were used to estimate national trends in
hospitalizations for three infectious conditions. Discharges where
ICD9-CMs were recorded for soft tissue infections (680.xx,
681.xx, and 682.xx), S aureus infections (038.11, 041.11, and
482.41), and MRSA (V09.0) were included in the study. NIS
discharge weights were used to generate nationally representative
estimates of discharges for each infection and for their combina-
tions with MRSA. Logistic regression was used to obtain odds
ratios (ORs) for each infection and MRSA combination (1 = yes,
0 = no) and the independent variables of patient age, race,
gender, income, hospital bedsize, location (urban/rural),
mission (teaching/non-teaching), and expected payment source.
RESULTS: From 1998 to 2004 discharges for soft tissue infec-
tions increased 47%, S aureus infections increased 28%, MRSA
increased 223%, MRSA with S aureus increased 317%, and
MRSA with soft tissue infection increased 608%. Regression
results for the S aureus with MRSA combination in 1998
revealed that being white, and older increased the odds of this
infection (ORs = 1.160 and 1.020 respectively) while being
female reduced the odds (OR = 0.692). Larger hospitals had a
lower odds (OR = 0.918) as did teaching hospitals (OR = 0.681).
However urban hospitals odds were higher (OR = 1.384) and
being a Medicare or Medicaid patient also was associated with
an increased odds of the infection (ORs = 1.486 and 1.743
respectively). Only patient income was not signiﬁcant (p < 0.001
for all other variables). Results for 2004 were similar but not
the same. CONCLUSION: Nosocomial infections continue to
increase as a percent of hospital stays, and the odds of infection
are not equal across patient and hospital types.
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To develop deterministic models for comparing the relative effec-
tiveness of various control measures, estimation of the spread
speed of the virus in the environment and the interactions
between spatial diffusion of birds and virus. Deterministic
models were developed based on the H5N1 transmission cycle by
partitioning the birds into three classes based on their epidemio-
logical characteristics for the disease under consideration:
poultry (c), wild birds—susceptible and die after H5N1 infection
(w), and wild birds—susceptible but survive after H5N1 infec-
tion without apparent disease symptoms (d). Model parameters
were obtained from existing literatures. Ordinary differential
equations (ODE) and partial differential equations (PDE) ana-
logues were utilized for the construction of models as described
below. ODE was used to access the effects of control measures,
one-dimensional PDE to study the spread speed of the disease,
Abstracts A107
